11. Employee Benefit Plans

Stock Incentive Plans

In September 2007, our stockholders approved the 2007 Omnibus Incentive Plan (the "2007 Plan"), which provides that options to purchase shares of our unissued common stock may be granted to our employees, officers, consultants and directors at exercise prices which are equal to or greater than the market value of our common stock on the date of grant. Options expire no more than ten years after the date of grant and generally vest at the rate of 25% on each of the first four anniversaries of the grant date. The 2007 Plan also allows for the issuance of stock appreciation rights, restricted stock, restricted stock units ("RSUs") and other stock-based awards based on the value of our common stock. New shares are issued to satisfy stock option exercises and share issuances under the 2007 Plan. In September 2009, our stockholders approved an amendment to increase the number of shares of our common stock authorized and reserved for issuance under the 2007 Plan by 800,000 shares to a total of 1,650,000 shares. In September 2012, our stockholders approved an amendment to increase the number of shares of our common stock authorized and reserved for issuance under the 2007 Plan by 800,000 shares to a total of 2,450,000 shares. In October 2014, our stockholders approved an amendment of the 2007 Plan to increase the number of shares of common stock authorized for issuance under the 2007 Plan by an additional 1,500,000 shares to a total of 3,950,000 shares. In September 2015, our stockholders approved an amendment of the 2007 Plan to increase the number of shares of common stock authorized for issuance under the 2007 Plan by an additional 1,000,000 shares to a total of 4,950,000 shares. In December 2016, our stockholders approved the 2016 Omnibus Incentive Plan (the "2016 Plan") which allows for the issuance of stock options, stock appreciation rights, restricted stock, RSUs", cash incentive awards and other stock-based awards to our employees, officers, consultants and directors at exercise prices which are equal to or greater than the market value of our common stock on the date of grant. Options expire no more than ten years after the date of grant and generally vest at the rate of 25% on each of the first four anniversaries of the grant date. Stock appreciation rights, restricted stock, RSUs and other stock-based awards are based on the value of our common stock. New shares are issued to satisfy stock option exercises and share issuances under the 2016 Plan.

We currently maintain both the 2007 Plan and the 2016 Plan. Of these plans, we may only grant future awards from the 2016 Plan. As of the 2016 Annual Meeting of Stockholders, no future shares could be granted under the 2007 Plan. At March 31, 2017, there were approximately 2.4 million shares of common stock available for grant under the 2016 plan. As of March 31, 2017, options to purchase approximately 2,942,000 shares of common stock, as well as 93,000 RSUs, were outstanding under the 2007 Plan and options to purchase approximately 835,000 shares of common stock, as well as 139,000 RSUs, were outstanding under the 2016 Plan.

Stock Options

A summary of activity in the Plans with respect to our stock options for Fiscal 2017 is as follows:

	Options			Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
	(In thousands)					(Years)		(In thousands)
Options outstanding at March 31, 2016		3,309		$	2.07
Granted		905			4.81
Exercised		(388	)		1.72
Forfeited		(37	)		2.25
Expired		(13	)		2.06

Options outstanding at March 31, 2017		3,776		$	2.76		8.0	$	10,115


Options exercisable at March 31, 2017		1,396		$	1.99		6.4	$	4,822


Vested and expected to vest at March 31, 2017		3,406		$	2.66		7.8	$	9,483


Options exercisable at March 31, 2017 pursuant to a change-in-control		3,776		$	2.76		8.0	$	10,115

Restricted Stock Units

RSU awards are stock-based awards that entitle the holder to receive one share of our common stock for each RSU upon vesting. RSUs granted under the 2007 Plan vest at the rate of 25% on each of the first four anniversaries of the grant date provided that the holder remains in service (as defined by the 2007 Plan) as of the vesting date. RSUs granted under the 2016 Plan vest at varying terms between one and four anniversaries of the grant date provided that the holder remains in service (as defined by the 2016 Plan) as of the vesting date. The fair value per RSU is determined based on the closing market price of our common stock on the grant date.

A summary of activity with respect to our RSUs for Fiscal 2017 is as follows:

	# of Shares			Weighted Average Price Per Share		Weighted Average Remaining Life		Aggregate Intrinsic Value
	(In thousands)					(Years)		(In thousands)
RSUs outstanding at March 31, 2016		173		$	2.00
Granted		141			4.98
Vested		(68	)		1.93
Forfeited		(14	)		2.05

RSUs outstanding at March 31, 2017		232		$	3.84		1.8	$	477


Expected to vest at March 31, 2017		180		$	3.83		1.7	$	377


Common stock issuable (for RSUs) at March 31, 2017 upon a change-in-control		232		$	3.84		1.8	$	477

Stock-Based Compensation

The following table presents stock-based compensation expense that is included in each functional line item in our consolidated statements of operations:

	Year Ended March 31,
	2017		2016		2015
	(In thousands)
Cost of revenues	$	51	$	42	$	21
Selling, general and administrative expense		858		567		315
Research and development expense		67		50		62

Total stock-based compensation	$	976	$	659	$	398

At March 31, 2017, there was approximately $2.8 million and $700,000 of unrecognized compensation expense related to unvested stock options and RSUs, respectively. This expense is currently expected to be recognized over a weighted average period of approximately 2.8 years for stock options and 1.8 years for RSUs. If there are any modifications or cancellations of the underlying unvested awards, we may be required to accelerate, increase or cancel any remaining unearned stock-based compensation expense. Future stock based compensation expense and unearned stock-based compensation will increase to the extent that we grant additional stock options, RSUs or other stock-based awards.

The grant date fair value of stock options granted was estimated using the following weighted-average assumptions:

	Year Ended March 31,
	2017			2016			2015
Expected life—years		6.5			7.2			7.7
Risk-free interest rate		2.2	%		1.9	%		2.0	%
Expected volatility of common stock		40	%		47	%		50	%
Dividend yield		—	%		—	%		—	%

A summary of certain fair value and intrinsic value information pertaining to our stock options is as follows:

	Year Ended March 31,
	2017		2016		2015
	(In thousands, except per share amounts)
Weighted average grant date fair value per share of options granted	$	2.11	$	1.19	$	1.01
Intrinsic value of options exercised	$	1,061	$	135	$	9

Employee Incentive Programs

Under the terms of a Profit Sharing Plan, we may contribute to a trust fund such amounts as determined annually by the Board of Directors. No contributions were made during the fiscal years ended March 31, 2017, 2016 and 2015.

We sponsor a defined contribution 401(k) plan (the "401(k) Plan"), adopted in 1990, under which eligible associates voluntarily contribute to the plan, up to IRS maximums, through payroll deductions. We match up to 50% of contributions, up to a stated limit, with all matching contributions being fully vested after three years of service. Our matching contributions under the 401(k) Plan were approximately $881,000, $716,000 and $495,000 for the fiscal years ended March 31, 2017, 2016 and 2015, respectively.